Predicting Cardiovascular Risk Factors for Acute Leukemia Patients by Assessing Subclinical Atherosclerosis and Left Ventricular Function Before Chemotherapy
Background: Subclinical atherosclerosis is a “silent” cardiovascular disease that can be devastating when combined with other illnesses. Its presence may affect therapy responses but can potentially worsen hematological malignancies due to most chemotherapy regimens’ cardiovascular adverse effects....
Saved in:
| Main Authors: | Anda Gabriela Militaru, Daniel Florin Lighezan, Anca Maria Cimpean, Elena Amaricai, Marius Militaru |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/15/5/704 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myocardial contractility dysfunction in patients with chronic lymphocytic leukemia receiving chemotherapy and their treatment with enalapril
by: I. L. Davydkin, et al.
Published: (2020-03-01) -
Assessment methods and possibilities of instrumental diagnosis of subclinical atherosclerosis of coronary arteries
by: N. E. Gavrilova, et al.
Published: (2019-12-01) -
Risk factors and subclinical carotid atherosclerosis in rotating scheme conditions in the Arctic
by: N. P. Shurkevich, et al.
Published: (2019-09-01) -
Frontiers in subclinical atherosclerosis and the latest in early life preventive cardiology
by: Mayank Dalakoti, et al.
Published: (2025-03-01) -
Triglyceride glucose index is associated with subclinical atherosclerosis and subclinical myocardial dysfunction in patients with newly diagnosed type 2 diabetes mellitus
by: S. H. Ustabas, et al.
Published: (2024-07-01)